GlaxoSmithKline Reportedly Settles 700 Avandia Cases
Drug maker GlaxoSmithKline has settled some 700 cases involving its diabetes drug Avandia, according to a Bloomberg news report. The Avandia lawsuits alleged that the drug caused them to suffer heart attacks and strokes. The settlement is reported to be around $60 million for the 700 claimants. That does not resolve all of the Avandia lawsuits, however. There are some 9,000 more claims that have not been filed under an agreement between the claimants and GlaxoSmithKline lawyers.
The first Avandia trial is due to begin this July in state court in Philadelphia.
Contact Kevin Dugan:
1-800-662-6230 or kdugan@arbd.com
1-800-662-6230 or kdugan@arbd.com
Latest posts by Kevin Dugan (see all)
- Racial Disparities in Health Care - January 18, 2021
- New Hampshire Doctor Who Plead Guilty to Sexually Assaulting a Patient Sentenced 5-10 Years - September 10, 2019
- Unsolicited Patient Observations Help Identify Surgeons More Likely to Commit Malpractice - August 1, 2018
